.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Chubb
Moodys
Queensland Health
Mallinckrodt
Teva
Julphar
Federal Trade Commission
UBS
QuintilesIMS

Generated: September 23, 2017

DrugPatentWatch Database Preview

Drug Master Files for: EPINEPHRINE

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
3875III7/4/19803M PHARMACEUTICALSADRENALINE (EPINEPHRINE) AND SALTS OF EPINEPHRINE
5779AII5/4/1984BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGEPINEPHRINE HYDROGENTARTRATE
5822AII5/29/1985BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGEPINEPHRINE
12037AII7/10/1996CAMBREX PROFARMACO MILANO SRLNOREPINEPHRINE BITARTRATE OR NORADRENALINE ACID TARTRATE
15367III3/30/2001WUHAN WUYAO PHARMACEUTICAL CO LTDNOREPINEPHRINE BITARTRATE USP, NON-STERILE, BULK DRUG
16344AII12/20/2002CHEMPACIFIC CORPNOREPINEPHRINE BITARTRATE
21213AII12/31/2007WOCKHARDT LTDEpinephrine USP
21716AII6/6/2008AMRI RENSSELAER INC SUB ALBANY MOLECULAR RESEARCH INCRACEPINEPHRINE HYDROCHLORIDE, USP DRUG SUBSTANCE
25874AII3/12/2012DERIVADOS QUIMICOS SAURACEPINEPHRINE HYDROCHLORIDE
25989AII4/13/2012CAMBREX PROFARMACO MILANO SRLEPINEPHRINE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
US Department of Justice
Colorcon
Queensland Health
Teva
McKinsey
Medtronic
Covington
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot